Jingjing Hu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 9
- Molecular Biology top 10%
- RNA modifications and cancer 10
- Circular RNAs in diseases 7
- Plant biochemistry and biosynthesis 6
- Genomics and Phylogenetic Studies 5
- Epigenetics and DNA Methylation 5
- Oncology top 10%
- Reproductive Medicine top 10%
-
- Salivary Gland Tumors Diagnosis and Treatment 6
- Co-authors
- Steven L. GoniasShupeng LiuKun YangYongchao ZhaoMinji JoScott R. VandenBergJunbo GeKai Cheng
- Journals
- Proceedings of the National Academy of Sciences (1 paper)SHILAP Revista de lepidopterología (3 papers)Gastroenterology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jingjing Hu
91 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 149
- Cancer Research 770
- Molecular Biology 1.3k
- Oncology 358
- Reproductive Medicine 86
- Immunology 215
Countries citing papers authored by Jingjing Hu
This map shows the geographic impact of Jingjing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Hu more than expected).
Fields of papers citing papers by Jingjing Hu
This network shows the impact of papers produced by Jingjing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Hu. The network helps show where Jingjing Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingjing Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 39 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 0 | |
| 15 | 2022 | 68 | |
| 16 | 2020 | 33 | |
| 17 | 2020 | 13 | |
| 18 | 2016 | 38 | |
| 19 | 2014 | 43 | |
| 20 | 2013 | 92 |
About Jingjing Hu
Jingjing Hu is a scholar working on Cancer Research, Reproductive Medicine and Molecular Biology, having authored 105 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers), Plant biochemistry and biosynthesis (6 papers), Salivary Gland Tumors Diagnosis and Treatment (6 papers), Genomics and Phylogenetic Studies (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (770 citations), Molecular Biology (1.3k citations) and Oncology (358 citations). Jingjing Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Steven L. Gonias, Shupeng Liu, Kun Yang, Yongchao Zhao, Minji Jo, Scott R. VandenBerg, Junbo Ge, Kai Cheng, Xiya Yu and Xiao Xiao. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.